A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro.

M.A.I. Abou el Hassan; MJ Rabelink; W.J.F. van der Vijgh; RC Hoeben

doi:10.1038/sj.bjc.6601430

A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro.

M.A.I. Abou el Hassan, MJ Rabelink, W.J.F. van der Vijgh, RC Hoeben

VU University medical center

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	2140-6
Journal	British Journal of Cancer
Volume	89
Issue number	11
DOIs	https://doi.org/10.1038/sj.bjc.6601430
Publication status	Published - 2003

Access to Document

10.1038/sj.bjc.6601430

Embargoed Document

PMC2376857
Final published version, 544 KB

Cite this

@article{57e7951eae9d49e6bc2041dbab5c76dc,

title = "A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro.",

author = "{Abou el Hassan}, M.A.I. and MJ Rabelink and {van der Vijgh}, W.J.F. and RC Hoeben",

year = "2003",

doi = "10.1038/sj.bjc.6601430",

language = "English",

volume = "89",

pages = "2140--6",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

number = "11",

}

A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro. / Abou el Hassan, M.A.I.; Rabelink, MJ; van der Vijgh, W.J.F. et al.
In: British Journal of Cancer, Vol. 89, No. 11, 2003, p. 2140-6.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro.

AU - Abou el Hassan, M.A.I.

AU - Rabelink, MJ

AU - van der Vijgh, W.J.F.

AU - Hoeben, RC

PY - 2003

Y1 - 2003

U2 - 10.1038/sj.bjc.6601430

DO - 10.1038/sj.bjc.6601430

M3 - Article

SN - 0007-0920

VL - 89

SP - 2140

EP - 2146

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 11

ER -